Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cockayne Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Cockayne Syndrome:

Pubmed Logo
Neuropathology of Cockayne syndrome: Evidence for impaired development, premature aging, and neurodegeneration.
Global growth and development failure, premature, accelerated, pathologic...
17th November, 2009
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, Mech Ageing Dev. 2009 Sep;130(9):619-36. Epub 2009 Jul 30.
DOI Direct Link
A Role for Checkpoint Kinase-Dependent Rad26 Phosphorylation in Transcription-Coupled DNA Repair in Saccharomyces cerevisiae.
Upon DNA damage, eukaryotic cells activate a conserved signal transduction...
11th November, 2009
Mechanisms of Transcription Laboratory, Clare Hall Laboratories, Cancer Mol Cell Biol. 2009 Nov 9.
DOI Direct Link
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome.
Cockayne syndrome is an autosomal recessive multisystem disorder...
7th November, 2009
Laboratory of Medical Genetics, University of Strasbourg, Strasbourg, Hum Mutat. 2009 Nov 5.
DOI Direct Link
Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.
Mutations in genes on the nucleotide excision repair pathway are...
7th November, 2009
Helen Diller Family Comprehensive Cancer Center, University of California Nat Rev Genet. 2009 Nov;10(11):756-68. Epub 2009 Oct 7.
DOI Direct Link
Progeroid syndromes and UV-induced oxidative DNA damage.
Progeroid syndromes are a group of diseases characterized by signs of...
5th November, 2009
Department of Dermatology, Molecular Oncology and Aging, Eberhard Karls J Investig Dermatol Symp Proc. 2009 Aug;14(1):8-14.
DOI Direct Link

View more research publications.

Press Releases About Cockayne Syndrome:

BioPortfolio Logo
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) 20th November, 2009 Merck & Co., Inc.
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
Oklahoma Medical Research Foundation Accelerates Discovery With Isilon IQ 18th November, 2009 Isilon Systems
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ -- IsilonĀ® Systems (Nasdaq: ISLN) today announced that the Oklahoma Medical Research Foundation (OMRF), a nonprofit biomedical research institute, has
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation 18th November, 2009 Albireo
GOTHENBURG, Sweden, November 18 /PRNewswire/ -- Albireo today announced the completion of a phase 1b study showing a favorable tolerability and safety profile of A3309 in patients with chronic
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation 18th November, 2009
GOTHENBURG, Sweden, November 18 /PRNewswire/ -- Albireo today announced the completion of a phase 1b study showing a favourable tolerability and safety profile of A3309 in patients with chronic

BioNews Results for Cockayne Syndrome:

RSS Logo
BioPortfolio Logo
Pharming Group N.V. (NL) - Pharming to present at Bio-Europe 2009
Pharma Live:  Oct 26 2009 7:41PM Matching: cockayne syndrome
Pharming Group (PHGUF.PK) Confirms Successful Closing Of Offer On Convertible Bonds
BioSpace:  Oct 14 2009 12:30AM Matching: cockayne syndrome
Pharming confirms successful closing of offer on convertible bonds
Pharma Live:  Oct 13 2009 9:34PM Matching: cockayne syndrome
Pharming confirms successful closing of offer on convertible bonds
RBC Dain Rauscher:  Oct 13 2009 5:35PM Matching: cockayne syndrome
DNage Initiates Observational Study In Children Suffering From Cockayne Syndrome
Pharmaceutical Business Review:  Sep 17 2009 8:51AM Matching: cockayne syndrome
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Cockayne Syndrome Patents:

USPTO Logo
US Patent No.Title
7097982 Peptides and compositions which modulate apoptosis
7291461 Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7297099 Use of osteopontin for the treatment and/or prevention of neurologic diseases
7308364 Diagnosis of multiple myeloma on gene expression profiling
7326690 Modulation of cell fates and activities by phthalazinediones

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Cockayne Syndrome scientists - we have details of around 75 individuals working on Cockayne Syndrome .


This page has been viewed 418 times
Recent Search Terms used to find this page: History of Cockayne syndrome | cockayne syndrome history | Cockayne Syndrome | cocayne syndrom biochemistry | syndrome de cochayne | syndrome de cochayne | Cockayne szindr ma | Cockayne manchester | blepharokeratoconjunctivitis cockayne syndrome | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Cockayne Syndrome across BioPortfolio, or for Cockayne Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.